Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.2 trillion and total revenue of $111.76 billion.
Market Cap
1.2T
Revenue
111.76B
Profits
-40.08B
PE Ratio
n/a
Profit Margin
-35.87%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.09B | -0.95% | 957,641 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.15B | 3.29% | 1,158,558 | 15.53B |
| 3 | ARGX | argenx SE | 53.60B | -2.15% | 294,612 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.87B | -2.41% | 1,491,781 | - |
| 5 | ONC | BeOne Medicines AG | 35.13B | -1.88% | 249,899 | 5.74B |
| 6 | RPRX | Royalty Pharma plc | 33.65B | -1.00% | 2,156,846 | 2.44B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 27.50B | 0.02% | 4,477,535 | 4.80B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.39B | -1.77% | 5,397,049 | 8.26M |
| 9 | INCY | Incyte Corporation | 24.23B | -2.82% | 1,829,492 | 5.82B |
| 10 | BNTX | BioNTech SE | 22.91B | -2.44% | 710,893 | 3.23B |
| 11 | MRNA | Moderna, Inc. | 21.75B | -5.35% | 7,764,504 | 2.23B |
| 12 | INSM | Insmed Incorporated | 21.37B | -2.85% | 2,899,367 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.56B | 0.80% | 2,057,334 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.08B | -2.85% | 508,875 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.88B | -2.14% | 572,224 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.66B | -2.50% | 2,132,592 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.33B | -5.25% | 3,025,174 | 2.38B |
| 18 | CORT | Corcept Therapeutics Incorporated | 12.38B | -3.24% | 1,840,751 | 830.81M |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.92B | -3.06% | 1,657,344 | 622.01M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | -0.92% | 2,377,098 | 3.24B |
| 21 | TECH | Bio-Techne Corporation | 11.23B | 0.08% | 4,033,711 | 1.21B |
| 22 | AXSM | Axsome Therapeutics, Inc. | 11.22B | -7.10% | 781,964 | 708.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.80B | -5.23% | 795,229 | 1.28B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.54B | 0.47% | 1,237,666 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.47B | -4.09% | 1,579,040 | 105.82M |
| 26 | SMMT | Summit Therapeutics Inc. | 10.39B | -3.12% | 3,995,115 | - |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.16% | 1,744,241 | - |
| 28 | KRYS | Krystal Biotech, Inc. | 10.06B | -7.01% | 488,404 | 417.30M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.79B | -0.91% | 1,558,885 | 1.51B |
| 30 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | -0.13% | 1,863,652 | 18.07M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 8.79B | -1.44% | 548,760 | 74.06M |
| 32 | SYRE | Spyre Therapeutics, Inc. | 8.65B | -3.12% | 613,606 | - |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 8.60B | -2.83% | 2,567,378 | 874.09M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.58B | 0.03% | 385,139 | 7.46M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 8.51B | -3.37% | 509,566 | 51.48M |
| 36 | IMVT | Immunovant, Inc. | 7.97B | -2.18% | 668,305 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.81B | -3.36% | 793,219 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.51B | -3.76% | 9,319,004 | 140.98M |
| 39 | TGTX | TG Therapeutics, Inc. | 7.37B | -2.80% | 2,489,739 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.80B | -6.14% | 471,702 | 217.17M |
| 41 | COGT | Cogent Biosciences, Inc. | 6.65B | -5.88% | 1,547,105 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.46B | -5.90% | 578,721 | 569.61M |
| 43 | ERAS | Erasca, Inc. | 6.30B | -2.84% | 2,696,382 | - |
| 44 | CGON | CG Oncology, Inc. | 6.28B | -2.52% | 560,803 | 5.07M |
| 45 | BLTE | Belite Bio, Inc | 6.24B | -0.82% | 159,281 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.06B | -2.37% | 736,904 | 7.50M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.84B | -5.08% | 1,075,498 | 1.34M |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.82B | -1.38% | 758,753 | - |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.78B | -2.18% | 1,965,585 | - |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.70B | -2.95% | 209,653 | 274.48M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.68B | -9.94% | 4,329,486 | 1.01B |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.67B | -3.46% | 786,736 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.20B | -2.43% | 1,715,028 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.73B | -0.93% | 1,036,224 | 4.10M |
| 55 | DYN | Dyne Therapeutics, Inc. | 4.70B | -2.14% | 1,824,986 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.43B | -2.56% | 1,534,198 | 1.10B |
| 57 | CAI | Caris Life Sciences, Inc. | 4.43B | -2.61% | 3,511,207 | 907.29M |
| 58 | MANE | Veradermics, Incorporated | 4.39B | 0.35% | 918,406 | - |
| 59 | PBLS | Parabilis Medicines, Inc. | 4.33B | 5.27% | 355,898 | - |
| 60 | CELC | Celcuity Inc. | 4.21B | -1.44% | 677,931 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | -6.54% | 1,150,032 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.10B | -3.19% | 1,785,597 | 10.68M |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.93B | -1.41% | 1,687,575 | 56.99M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 3.83B | 1.59% | 660,413 | - |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.69B | -4.14% | 1,867,338 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.65B | -5.46% | 1,231,814 | - |
| 67 | ALMS | Alumis Inc. | 3.60B | -2.42% | 1,321,120 | 8.40M |
| 68 | LEGN | Legend Biotech Corporation | 3.59B | -2.62% | 2,718,056 | 1.14B |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.55B | -0.21% | 1,270,691 | 236.00M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.41B | -2.89% | 407,245 | - |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.39B | -1.69% | 80,919 | 803.79M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.38B | -2.47% | 479,797 | 225.27M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -4.04% | 1,548,715 | 415.62M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | -2.35% | 956,575 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 3.14B | -0.80% | 565,807 | - |
| 76 | QURE | uniQure N.V. | 3.03B | 3.41% | 1,695,179 | 18.67M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.99B | -1.10% | 875,347 | 865.00K |
| 78 | IRON | Disc Medicine, Inc. | 2.94B | -2.79% | 363,764 | - |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | - | 8,917,253 | 3.49M |
| 80 | KOD | Kodiak Sciences Inc. | 2.60B | -2.16% | 426,202 | - |
| 81 | TRVI | Trevi Therapeutics, Inc. | 2.59B | -0.82% | 1,350,334 | - |
| 82 | IMNM | Immunome, Inc. | 2.58B | -1.39% | 657,786 | 4.02M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.54B | -3.66% | 1,068,071 | 164.01M |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -0.84% | 637,019 | 535.08M |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -4.34% | 1,537,765 | 670.00M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.41B | -1.57% | 761,615 | 36.77M |
| 87 | NKTR | Nektar Therapeutics | 2.39B | -1.09% | 497,059 | 55.63M |
| 88 | VCEL | Vericel Corporation | 2.35B | -3.47% | 521,407 | 306.30M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.30B | -2.87% | 1,443,691 | - |
| 90 | PHVS | Pharvaris N.V. | 2.28B | -3.72% | 507,253 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -2.56% | 618,119 | - |
| 92 | PGEN | Precigen, Inc. | 2.24B | 5.56% | 5,624,066 | 31.60M |
| 93 | COAG | Hemab Therapeutics Holdings, Inc. | 2.22B | 0.17% | 447,272 | - |
| 94 | NUVB | Nuvation Bio Inc. | 2.20B | -5.52% | 4,890,889 | 143.05M |
| 95 | KLRA | Kailera Therapeutics, Inc. | 2.19B | -0.65% | 411,267 | - |
| 96 | SION | Sionna Therapeutics, Inc. | 2.13B | 0.75% | 392,309 | - |
| 97 | VRDN | Viridian Therapeutics, Inc. | 2.09B | -4.92% | 1,088,027 | 70.92M |
| 98 | ZLAB | Zai Lab Limited | 2.05B | 0.33% | 353,712 | 453.28M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -1.73% | 604,686 | 899.11M |
| 100 | BHVN | Biohaven Ltd. | 2.03B | -2.32% | 1,429,647 | - |
| 101 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -7.42% | 185,670 | - |
| 102 | ZBIO | Zenas BioPharma, Inc. | 1.98B | -2.57% | 452,226 | 10.00M |
| 103 | SLS | SELLAS Life Sciences Group, Inc. | 1.97B | -2.72% | 5,043,890 | - |
| 104 | NBTX | Nanobiotix S.A. | 1.97B | -4.41% | 129,986 | 38.27M |
| 105 | ADMA | ADMA Biologics, Inc. | 1.96B | -2.42% | 1,619,877 | 509.86M |
| 106 | RAPP | Rapport Therapeutics, Inc. | 1.96B | -4.21% | 240,878 | 20.00M |
| 107 | GHRS | GH Research PLC | 1.93B | -1.09% | 177,769 | - |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | -0.80% | 1,400,061 | 298.30M |
| 109 | TYRA | Tyra Biosciences, Inc. | 1.90B | -3.57% | 712,719 | - |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 1.87B | -0.26% | 2,287,897 | 7.47M |
| 111 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.49% | 794,042 | - |
| 112 | MESO | Mesoblast Limited | 1.87B | -2.61% | 159,413 | 65.38M |
| 113 | URGN | UroGen Pharma Ltd. | 1.86B | -6.94% | 814,677 | 140.49M |
| 114 | KARD | Kardigan, Inc. | 1.86B | 1.71% | 280,613 | - |
| 115 | FTRE | Fortrea Holdings Inc. | 1.82B | 0.47% | 1,910,837 | 2.68B |
| 116 | IOVA | Iovance Biotherapeutics, Inc. | 1.82B | -13.22% | 19,940,923 | 285.61M |
| 117 | LKFT | Lakefront Biotherapeutics NV | 1.81B | -1.56% | 176,795 | 1.20B |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.80B | -3.93% | 715,803 | 32.08M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.79B | -0.21% | 318,336 | 30.30M |
| 120 | OCUL | Ocular Therapeutix, Inc. | 1.79B | -3.54% | 2,151,848 | 52.04M |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -8.34% | 2,101,901 | 98.34M |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.78B | -0.75% | 314,511 | - |
| 123 | BCAX | Bicara Therapeutics Inc. | 1.78B | 3.16% | 690,011 | - |
| 124 | ABCL | AbCellera Biologics Inc. | 1.74B | 0.35% | 5,011,667 | 79.21M |
| 125 | IMCR | Immunocore Holdings plc | 1.72B | -0.18% | 761,726 | 412.81M |
| 126 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -2.67% | 1,087,352 | 204.73M |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -2.21% | 1,206,281 | 217.17M |
| 128 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -1.32% | 14,028,772 | 66.41M |
| 129 | AAPG | Ascentage Pharma Group International | 1.59B | -3.57% | 3,993 | 82.08M |
| 130 | ANAB | AnaptysBio, Inc. | 1.58B | -3.05% | 451,303 | 232.39M |
| 131 | ZYME | Zymeworks Inc. | 1.57B | -3.39% | 375,123 | 81.26M |
| 132 | SRPT | Sarepta Therapeutics, Inc. | 1.57B | -4.50% | 3,603,368 | 2.18B |
| 133 | SEPN | Septerna, Inc. | 1.55B | -2.08% | 241,069 | 72.26M |
| 134 | INVA | Innoviva, Inc. | 1.55B | -1.18% | 505,256 | 420.69M |
| 135 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | -7.83% | 869,660 | - |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.52B | -2.90% | 791,757 | - |
| 137 | XNCR | Xencor, Inc. | 1.50B | -5.96% | 1,318,698 | 97.36M |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.49B | -3.70% | 2,203,042 | 66.09M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.49B | -2.57% | 335,545 | 20.00M |
| 140 | VIR | Vir Biotechnology, Inc. | 1.46B | -2.70% | 1,126,881 | 65.50M |
| 141 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -27.16% | 7,447,452 | 42.95M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.74% | 427,771 | - |
| 143 | SVRA | Savara Inc. | 1.38B | -1.44% | 1,168,541 | - |
| 144 | ABSI | Absci Corporation | 1.32B | 1.83% | 2,085,549 | 1.84M |
| 145 | AVLN | Avalyn Pharma Inc. | 1.28B | -1.77% | 126,781 | - |
| 146 | MNKD | MannKind Corporation | 1.25B | -4.87% | 5,404,120 | 360.78M |
| 147 | ARDX | Ardelyx, Inc. | 1.22B | -1.79% | 2,762,665 | 427.68M |
| 148 | AKTS | Aktis Oncology, Inc. | 1.22B | -4.04% | 278,383 | 8.28M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -3.16% | 108,220 | 1.30M |
| 150 | NVAX | Novavax, Inc. | 1.20B | -1.61% | 2,773,161 | 596.34M |
| 151 | IMTX | Immatics N.V. | 1.18B | -5.87% | 211,633 | 43.00M |
| 152 | JBIO | Jade Biosciences, Inc. | 1.17B | -1.25% | 594,990 | - |
| 153 | LBRX | LB Pharmaceuticals Inc | 1.15B | -2.00% | 338,246 | - |
| 154 | VOR | Vor Biopharma Inc. | 1.15B | -2.98% | 904,879 | - |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | -4.90% | 1,238,821 | - |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 0.53% | 775,582 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.10B | 0.69% | 115,644 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.09B | -1.59% | 516,765 | 79.76M |
| 159 | WVE | Wave Life Sciences Ltd. | 1.09B | -4.34% | 2,866,718 | 65.37M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.06B | -0.84% | 272,113 | - |
| 161 | ANRO | Alto Neuroscience, Inc. | 1.05B | -5.45% | 323,668 | - |
| 162 | IVA | Inventiva S.A. | 1.03B | -3.03% | 1,352,865 | 7.94M |
| 163 | EYPT | EyePoint, Inc. | 1.03B | -4.74% | 1,711,083 | 7.61M |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 2,767,750 | 69.64M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -5.82% | 839,529 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.00B | -3.13% | 709,777 | - |
| 167 | APMD | Apnimed, Inc. | 999.99M | 56.25% | 3,429,261 | 120.15M |
| 168 | AVTX | Avalo Therapeutics, Inc. | 965.48M | -5.88% | 923,877 | 59.00K |
| 169 | REPL | Replimune Group, Inc. | 940.40M | 107.02% | 33,629,890 | - |
| 170 | SANA | Sana Biotechnology, Inc. | 938.69M | -3.69% | 2,308,119 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 925.13M | -2.63% | 509,555 | 13.73M |
| 172 | ODTX | Odyssey Therapeutics, Inc. | 906.33M | 2.77% | 183,243 | 1.06M |
| 173 | TBPH | Theravance Biopharma, Inc. | 873.82M | 0.06% | 369,695 | 109.78M |
| 174 | ABUS | Arbutus Biopharma Corporation | 857.31M | -1.59% | 1,167,946 | 191.45M |
| 175 | OMER | Omeros Corporation | 856.92M | -0.75% | 1,309,589 | 9.89M |
| 176 | ANNX | Annexon, Inc. | 834.78M | -3.32% | 2,800,726 | - |
| 177 | GERN | Geron Corporation | 827.56M | -3.73% | 19,589,837 | 196.12M |
| 178 | DBVT | DBV Technologies S.A. | 799.95M | -2.24% | 351,681 | 5.04M |
| 179 | KURA | Kura Oncology, Inc. | 799.86M | -3.22% | 1,169,781 | 71.64M |
| 180 | SLDB | Solid Biosciences Inc. | 793.50M | -5.06% | 1,060,556 | - |
| 181 | AURA | Aura Biosciences, Inc. | 773.20M | -1.41% | 294,062 | - |
| 182 | DSGN | Design Therapeutics, Inc. | 760.73M | -3.49% | 628,260 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 753.25M | -0.84% | 53,657 | - |
| 184 | CADL | Candel Therapeutics, Inc. | 733.44M | 1.42% | 1,117,469 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 731.41M | -1.84% | 212,595 | - |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 726.25M | -2.26% | 1,638,334 | 8.37M |
| 187 | MNPR | Monopar Therapeutics Inc. | 725.81M | -5.50% | 431,271 | - |
| 188 | PHAR | Pharming Group N.V. | 713.48M | -6.23% | 26,687 | 366.48M |
| 189 | FTH | Faeth Therapeutics, Inc. | 702.21M | -5.48% | 225,956 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 699.96M | -9.27% | 1,575,876 | - |
| 191 | PHAT | Phathom Pharmaceuticals, Inc. | 695.01M | -3.10% | 3,312,139 | 239.66M |
| 192 | OCS | Oculis Holding AG | 682.99M | 0.89% | 204,845 | 1.40M |
| 193 | CLYM | Climb Bio, Inc. | 681.40M | -1.49% | 546,419 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 681.06M | -3.28% | 174,912 | 299.77M |
| 195 | NVCT | Nuvectis Pharma, Inc. | 678.43M | -5.45% | 158,601 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 674.88M | -5.49% | 3,502,360 | 35.54M |
| 197 | ACHV | Achieve Life Sciences, Inc. | 659.07M | 1.90% | 1,181,692 | - |
| 198 | NGNE | Neurogene Inc. | 655.40M | -2.11% | 118,361 | 925.00K |
| 199 | ALLO | Allogene Therapeutics, Inc. | 648.89M | -4.57% | 5,521,843 | 22.00K |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 648.07M | -4.82% | 368,245 | - |
| 201 | GYRE | Gyre Therapeutics, Inc. | 641.06M | -1.03% | 47,589 | 117.05M |
| 202 | AGMB | AgomAb Therapeutics NV | 633.82M | 0.90% | 53,475 | - |
| 203 | MDXG | MiMedx Group, Inc. | 615.15M | -3.28% | 2,987,491 | 355.17M |
| 204 | CBIO | Crescent Biopharma, Inc. | 597.96M | -3.66% | 292,363 | 11.88M |
| 205 | RGNX | REGENXBIO Inc. | 597.90M | -4.25% | 1,157,433 | 87.82M |
| 206 | IMMX | Immix Biopharma, Inc. | 592.30M | -2.69% | 1,578,095 | - |
| 207 | CRMD | CorMedix Inc. | 590.74M | 0.53% | 637,205 | 400.05M |
| 208 | MPLT | MapLight Therapeutics, Inc. | 590.40M | -7.20% | 1,149,085 | - |
| 209 | CTNM | Contineum Therapeutics, Inc. | 579.11M | -1.65% | 449,367 | - |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 562.18M | -1.35% | 971,429 | 122.29M |
| 211 | RLMD | Relmada Therapeutics, Inc. | 556.97M | -0.75% | 1,717,939 | - |
| 212 | ALT | Altimmune, Inc. | 552.31M | -4.70% | 3,892,079 | 36.00K |
| 213 | STTK | Shattuck Labs, Inc. | 542.13M | -1.67% | 660,438 | 1.00M |
| 214 | FDMT | 4D Molecular Therapeutics, Inc. | 532.17M | 1.09% | 716,312 | 88.24M |
| 215 | TECX | Tectonic Therapeutic, Inc. | 528.90M | -1.68% | 253,092 | - |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.48M | - | 629,806 | 151.40M |
| 217 | PRME | Prime Medicine, Inc. | 527.40M | -3.31% | 1,834,314 | 4.03M |
| 218 | ANL | Adlai Nortye Ltd. | 520.00M | - | 120,408 | 5.00M |
| 219 | ARVN | Arvinas, Inc. | 518.11M | -3.25% | 687,857 | 89.40M |
| 220 | ZURA | Zura Bio Limited | 515.84M | -1.99% | 541,147 | - |
| 221 | VSTM | Verastem, Inc. | 509.67M | -4.92% | 1,857,156 | 49.59M |
| 222 | SPRY | ARS Pharmaceuticals, Inc. | 509.43M | -8.88% | 2,083,370 | 98.99M |
| 223 | EIKN | Eikon Therapeutics, Inc. | 498.62M | -4.26% | 235,381 | - |
| 224 | SLN | Silence Therapeutics plc | 495.48M | -9.72% | 556,511 | 839.00K |
| 225 | RZLT | Rezolute, Inc. | 493.08M | -3.28% | 776,942 | - |
| 226 | ARTV | Artiva Biotherapeutics, Inc. | 490.74M | -3.16% | 323,633 | 251.00K |
| 227 | HELP | Cybin Inc. | 484.72M | -3.93% | 686,492 | - |
| 228 | ASMB | Assembly Biosciences, Inc. | 483.39M | -3.65% | 101,353 | 71.10M |
| 229 | VALN | Valneva SE | 468.61M | -2.28% | 23,010 | 180.25M |
| 230 | QTTB | Q32 Bio Inc. | 466.70M | 0.77% | 386,806 | 53.74M |
| 231 | PROK | ProKidney Corp. | 465.17M | -2.53% | 809,053 | 889.00K |
| 232 | PRLD | Prelude Therapeutics Incorporated | 456.22M | -8.91% | 261,589 | 16.72M |
| 233 | KYTX | Kyverna Therapeutics, Inc. | 443.81M | -2.54% | 526,071 | - |
| 234 | SGMT | Sagimet Biosciences Inc. | 439.06M | -2.74% | 616,133 | - |
| 235 | CABA | Cabaletta Bio, Inc. | 436.99M | -1.47% | 1,907,662 | - |
| 236 | SLBT | SL Science Holding Limited | 427.50M | -1.67% | 15,653 | 3.36M |
| 237 | IKT | Inhibikase Therapeutics, Inc. | 426.02M | -4.39% | 369,378 | 1.00 |
| 238 | PRTA | Prothena Corporation plc | 425.11M | -3.45% | 545,490 | 57.94M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 418.17M | -2.29% | 456,258 | - |
| 240 | OCGN | Ocugen, Inc. | 416.38M | -2.38% | 4,149,005 | 4.47M |
| 241 | OVID | Ovid Therapeutics Inc. | 414.34M | -6.33% | 1,593,403 | 7.12M |
| 242 | EVMN | Evommune, Inc. | 405.21M | -0.88% | 302,959 | 10.00M |
| 243 | PBYI | Puma Biotechnology, Inc. | 403.63M | 0.51% | 264,861 | 227.18M |
| 244 | BNTC | Benitec Biopharma Inc. | 402.29M | -1.26% | 107,525 | - |
| 245 | VTVT | vTv Therapeutics Inc. | 401.45M | -1.01% | 136,838 | 36.84M |
| 246 | STRO | Sutro Biopharma, Inc. | 400.51M | -2.62% | 163,196 | 99.61M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 398.74M | -0.13% | 938,769 | - |
| 248 | AUTL | Autolus Therapeutics plc | 396.55M | -2.61% | 815,252 | 92.62M |
| 249 | EDIT | Editas Medicine, Inc. | 395.93M | -4.09% | 1,180,097 | 38.69M |
| 250 | CCCC | C4 Therapeutics, Inc. | 384.77M | -4.92% | 1,949,817 | 34.86M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 376.13M | -0.84% | 471,928 | - |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 375.39M | -0.50% | 415,481 | 9.01M |
| 253 | SCTX | Scribe Therapeutics Inc. | 367.48M | -4.51% | 100,134 | 36.28M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 366.39M | -3.08% | 143,656 | 69.21M |
| 255 | ABEO | Abeona Therapeutics Inc. | 365.91M | -0.77% | 662,352 | 14.54M |
| 256 | IPSC | Century Therapeutics, Inc. | 364.32M | -7.76% | 446,054 | 109.16M |
| 257 | CMPX | Compass Therapeutics, Inc. | 343.97M | -1.55% | 2,640,537 | 850.00K |
| 258 | UPB | Upstream Bio, Inc. | 343.39M | -3.96% | 297,649 | 3.32M |
| 259 | DMAC | DiaMedica Therapeutics Inc. | 341.62M | -2.61% | 99,023 | - |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 339.59M | -3.12% | 1,281,506 | - |
| 261 | ZNTL | Zentalis Pharmaceuticals, Inc. | 337.42M | -3.66% | 941,162 | 26.87M |
| 262 | AGEN | Agenus Inc. | 335.64M | -5.18% | 1,573,777 | 123.87M |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 332.43M | -3.43% | 86,483 | 51.00M |
| 264 | PALI | Palisade Bio, Inc. | 328.93M | -3.32% | 1,853,421 | - |
| 265 | VCRE | Vicore Pharma Holding AB (publ) | 328.24M | 0.26% | 1,124 | 370.61K |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 324.29M | -5.06% | 713,512 | - |
| 267 | CUVL | Clinuvel Pharmaceuticals Limited | 320.71M | -6.35% | 4,101 | 64.24M |
| 268 | LYEL | Lyell Immunopharma, Inc. | 317.09M | -5.69% | 126,652 | 31.00K |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 306.69M | -1.54% | 539,518 | 217.78M |
| 270 | IRD | Opus Genetics, Inc. | 306.32M | -3.39% | 969,740 | 11.98M |
| 271 | NMRA | Neumora Therapeutics, Inc. | 298.31M | -2.42% | 1,626,667 | - |
| 272 | OABI | OmniAb, Inc. | 287.05M | -0.50% | 275,281 | 28.94M |
| 273 | FATE | Fate Therapeutics, Inc. | 285.57M | -2.39% | 1,458,628 | 6.32M |
| 274 | SABS | SAB Biotherapeutics, Inc. | 272.98M | 0.28% | 405,012 | 114.70K |
| 275 | NAGE | Niagen Bioscience, Inc. | 271.36M | 2.41% | 648,500 | 130.42M |
| 276 | BCYC | Bicycle Therapeutics plc | 269.47M | -3.74% | 336,058 | 61.21M |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 269.24M | -2.70% | 875,631 | 14.78M |
| 278 | SLGL | Sol-Gel Technologies Ltd. | 268.87M | -3.45% | 74,057 | 18.47M |
| 279 | IMRX | Immuneering Corporation | 267.20M | -2.36% | 365,067 | - |
| 280 | FHTX | Foghorn Therapeutics Inc. | 265.97M | -4.43% | 156,485 | 28.22M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 261.28M | -0.88% | 642,030 | - |
| 282 | ALXO | ALX Oncology Holdings Inc. | 261.05M | -0.51% | 703,611 | - |
| 283 | SRZN | Surrozen, Inc. | 257.87M | 6.63% | 304,176 | 7.49M |
| 284 | AVXL | Anavex Life Sciences Corp. | 254.85M | 1.85% | 1,198,549 | - |
| 285 | IFRX | InflaRx N.V. | 250.40M | -1.16% | 583,860 | 33.82K |
| 286 | TTRX | Turn Therapeutics Inc. | 249.03M | 1.33% | 46,513 | - |
| 287 | ADAG | Adagene Inc. | 247.77M | 0.54% | 152,203 | 7.67M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 244.67M | 0.30% | 352,588 | 5.74M |
| 289 | PRQR | ProQR Therapeutics N.V. | 242.73M | -3.37% | 1,015,017 | 15.73M |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 238.55M | -3.76% | 3,519,353 | 80.00M |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 238.33M | -0.25% | 153,851 | 32.72M |
| 292 | MGNX | MacroGenics, Inc. | 234.55M | -2.38% | 410,745 | 157.08M |
| 293 | RNAC | Cartesian Therapeutics, Inc. | 229.18M | 0.91% | 140,188 | 1.78M |
| 294 | CAPR | Capricor Therapeutics, Inc. | 222.96M | -8.11% | 7,297,140 | 11.13M |
| 295 | CNXU | Conexeu Sciences Inc. | 222.36M | -5.89% | 165,778 | - |
| 296 | CGEN | Compugen Ltd. | 222.27M | 0.64% | 349,763 | 72.66M |
| 297 | TARA | Protara Therapeutics, Inc. | 220.60M | -2.73% | 294,520 | - |
| 298 | CHRS | Coherus Oncology, Inc. | 217.49M | -4.08% | 437,143 | 46.88M |
| 299 | ACIU | AC Immune SA | 217.25M | -7.59% | 228,983 | 4.62M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 207.07M | - | 309,831 | 7.15M |
| 301 | CLLS | Cellectis S.A. | 206.12M | -3.51% | 12,724 | 75.11M |
| 302 | KROS | Keros Therapeutics, Inc. | 199.30M | -1.47% | 144,750 | 33.18M |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 198.16M | -3.71% | 85,350 | - |
| 304 | GALT | Galectin Therapeutics Inc. | 195.59M | -8.05% | 387,691 | - |
| 305 | RNA | Atrium Therapeutics, Inc. | 194.15M | -0.96% | 116,292 | 36.68M |
| 306 | ANTX | AN2 Therapeutics, Inc. | 192.69M | 0.38% | 250,510 | - |
| 307 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | 4.41% | 1,195,595 | 76.38M |
| 308 | IMUX | Immunic, Inc. | 190.29M | -0.14% | 145,975 | - |
| 309 | NERV | Minerva Neurosciences, Inc. | 185.42M | -1.00% | 70,694 | - |
| 310 | NBP | NovaBridge Biosciences | 185.04M | -2.44% | 169,164 | - |
| 311 | VYGR | Voyager Therapeutics, Inc. | 183.08M | -3.19% | 418,922 | 36.49M |
| 312 | OTLK | Outlook Therapeutics, Inc. | 182.62M | -6.10% | 8,191,257 | 333.14K |
| 313 | MDWD | MediWound Ltd. | 181.47M | 0.14% | 75,361 | 14.48M |
| 314 | DTIL | Precision BioSciences, Inc. | 180.36M | -0.14% | 211,108 | 45.07M |
| 315 | ACOG | Alpha Cognition Inc. | 180.29M | -5.15% | 154,510 | 10.83M |
| 316 | CAMP | Camp4 Therapeutics Corporation | 179.14M | -0.58% | 91,214 | 3.93M |
| 317 | HUMA | Humacyte, Inc. | 176.18M | -2.71% | 1,746,469 | 2.02M |
| 318 | NGEN | NervGen Pharma Corp. | 172.39M | 1.25% | 299,503 | - |
| 319 | ALEC | Alector, Inc. | 167.65M | -6.79% | 548,293 | 18.42M |
| 320 | PYXS | Pyxis Oncology, Inc. | 167.58M | -7.67% | 750,101 | 13.86M |
| 321 | ARMP | Armata Pharmaceuticals, Inc. | 166.67M | -5.02% | 26,457 | 5.20M |
| 322 | ORMP | Oramed Pharmaceuticals Inc. | 166.57M | -1.21% | 208,668 | 2.00M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.19M | -0.88% | 348,854 | - |
| 324 | LENZ | LENZ Therapeutics, Inc. | 166.18M | -7.99% | 862,820 | 20.99M |
| 325 | IPHA | Innate Pharma S.A. | 165.31M | 0.29% | 9,283 | 10.57M |
| 326 | ARCT | Arcturus Therapeutics Holdings Inc. | 163.72M | -2.70% | 267,160 | 54.71M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 160.64M | -1.29% | 1,624,618 | 225.00K |
| 328 | MENS | Jyong Biotech Ltd. | 159.60M | -3.59% | 70,426 | - |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 159.57M | -0.79% | 468,104 | 17.56M |
| 330 | IVVD | Invivyd, Inc. | 157.61M | -8.01% | 2,301,588 | 55.87M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 155.29M | -0.92% | 263,176 | - |
| 332 | MOLN | Molecular Partners AG | 154.38M | - | 90 | 856.30K |
| 333 | OKUR | OnKure Therapeutics, Inc. | 154.31M | -4.50% | 239,635 | - |
| 334 | YDES | YD Bio Limited | 152.59M | -1.36% | 9,855 | 510.36K |
| 335 | MIST | Milestone Pharmaceuticals Inc. | 151.02M | -3.48% | 1,006,850 | 1.78M |
| 336 | KRRO | Korro Bio, Inc. | 149.56M | -0.77% | 115,191 | 3.84M |
| 337 | NKTX | Nkarta, Inc. | 149.53M | -2.79% | 683,231 | - |
| 338 | CNTN | Canton Strategic Holdings, Inc. | 148.85M | 4.32% | 1,179,049 | - |
| 339 | ENTX | Entera Bio Ltd. | 147.38M | 1.36% | 1,059,700 | 42.00K |
| 340 | CBUS | Cibus, Inc. | 147.32M | - | 141,624 | 4.29M |
| 341 | INDP | Indaptus Therapeutics, Inc. | 146.08M | -10.42% | 92,506 | - |
| 342 | CRBU | Caribou Biosciences, Inc. | 144.80M | -3.31% | 1,127,649 | 11.20M |
| 343 | KZIA | Kazia Therapeutics Limited | 144.21M | -1.56% | 297,790 | 1.27M |
| 344 | AARD | Aardvark Therapeutics, Inc. | 143.99M | 3.12% | 89,270 | - |
| 345 | EQ | Equillium, Inc. | 139.10M | -5.17% | 728,933 | 4.39M |
| 346 | HURA | TuHURA Biosciences, Inc. | 138.19M | - | 142,862 | - |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 137.24M | -5.47% | 486,270 | - |
| 348 | TLSA | Tiziana Life Sciences Ltd | 133.19M | 6.19% | 388,460 | - |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 132.02M | 0.96% | 1,147,529 | 2.29M |
| 350 | GNLX | Genelux Corporation | 130.56M | -3.61% | 374,938 | 8.00K |
| 351 | CDXS | Codexis, Inc. | 127.26M | -5.41% | 1,134,785 | 78.09M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 127.19M | -3.35% | 294,513 | 233.00K |
| 353 | NAUT | Nautilus Biotechnology, Inc. | 124.33M | -5.15% | 925,043 | 190.00K |
| 354 | PMN | ProMIS Neurosciences, Inc. | 123.04M | -8.04% | 33,785 | - |
| 355 | SEER | Seer, Inc. | 122.06M | 7.77% | 2,903,581 | 15.17M |
| 356 | PEPG | PepGen Inc. | 121.74M | -1.12% | 296,232 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 119.91M | 1.70% | 306,172 | - |
| 358 | SPRB | Spruce Biosciences, Inc. | 117.88M | -1.25% | 23,403 | 697.00K |
| 359 | ANIX | Anixa Biosciences, Inc. | 116.36M | -3.93% | 170,216 | - |
| 360 | CUE | Cue Biopharma, Inc. | 112.74M | -11.71% | 474,890 | 32.73M |
| 361 | VANI | Vivani Medical, Inc. | 111.24M | -1.54% | 29,279 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 109.36M | 7.44% | 204,166 | - |
| 363 | GUTS | Fractyl Health, Inc. | 108.67M | -0.72% | 621,060 | 3.00K |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 105.56M | -5.63% | 436,458 | 3.17M |
| 365 | FBIO | Fortress Biotech, Inc. | 103.98M | -4.86% | 642,753 | 66.16M |
| 366 | ICCC | ImmuCell Corporation | 101.41M | 1.36% | 10,144 | 29.93M |
| 367 | PTHS | Pelthos Therapeutics Inc. | 99.61M | 9.18% | 323,446 | 27.70M |
| 368 | COYA | Coya Therapeutics, Inc. | 98.29M | 2.70% | 179,951 | 7.94M |
| 369 | YARW | Yarrow Bioscience, Inc. | 98.06M | 6.15% | 18,482 | - |
| 370 | BDTX | Black Diamond Therapeutics, Inc. | 96.84M | -1.46% | 623,019 | 70.00M |
| 371 | ACET | Adicet Bio, Inc. | 95.66M | 0.55% | 123,284 | - |
| 372 | HRTX | Heron Therapeutics, Inc. | 93.92M | -0.24% | 1,335,172 | 150.71M |
| 373 | ALDX | Aldeyra Therapeutics, Inc. | 92.89M | -3.75% | 576,754 | - |
| 374 | NTHI | NeOnc Technologies Holdings, Inc. | 90.51M | - | 63,236 | 39.99K |
| 375 | ONCY | Oncolytics Biotech Inc. | 89.91M | 0.04% | 834,846 | - |
| 376 | VRCA | Verrica Pharmaceuticals Inc. | 89.67M | -0.76% | 5,043 | 37.16M |
| 377 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 25,799 | - |
| 378 | BMEA | Biomea Fusion, Inc. | 84.59M | -4.10% | 449,874 | - |
| 379 | RLYB | Rallybio Corporation | 84.40M | -0.87% | 18,104 | 858.00K |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 83.51M | 0.86% | 71,788 | - |
| 381 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | -3.20% | 43,813 | - |
| 382 | ATHE | Alterity Therapeutics Limited | 83.21M | -1.78% | 3,730 | 4.43M |
| 383 | GOSS | Gossamer Bio, Inc. | 82.86M | -4.94% | 25,592,201 | 55.54M |
| 384 | PYPD | PolyPid Ltd. | 82.26M | -1.83% | 115,356 | - |
| 385 | CGTX | Cognition Therapeutics, Inc. | 79.62M | -2.88% | 407,357 | - |
| 386 | NRXS | NeurAxis, Inc. | 77.40M | -0.48% | 42,899 | 4.28M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 76.00M | - | 217,344 | - |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 75.51M | 2.57% | 34,489 | 23.14M |
| 389 | CSBR | Champions Oncology, Inc. | 74.47M | 1.90% | 2,002 | 59.43M |
| 390 | ANVS | Annovis Bio, Inc. | 74.45M | -1.13% | 353,012 | - |
| 391 | GANX | Gain Therapeutics, Inc. | 71.66M | -4.55% | 230,645 | - |
| 392 | ELOX | Eloxx Pharmaceuticals, Inc. | 70.35M | 31.05% | 53,355 | - |
| 393 | IBIO | iBio, Inc. | 69.55M | 0.72% | 727,845 | 300.00K |
| 394 | RNTX | Rein Therapeutics Inc. | 68.61M | -3.98% | 391,662 | - |
| 395 | ALPS | Alps Group Inc | 68.27M | -9.40% | 17,381 | 3.74M |
| 396 | XBIT | XBiotech Inc. | 67.99M | -0.45% | 37,801 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 67.74M | -2.50% | 784,004 | 61.19M |
| 398 | OSTX | OS Therapies Incorporated | 67.70M | -2.56% | 325,885 | - |
| 399 | LONA | LeonaBio, Inc. | 66.32M | -3.16% | 6,580 | - |
| 400 | ELTX | Elicio Therapeutics, Inc. | 65.67M | -3.78% | 406,906 | - |
| 401 | MNOV | MediciNova, Inc. | 65.46M | -0.75% | 8,036 | 596.64K |
| 402 | CING | Cingulate Inc. | 64.52M | 0.63% | 60,543 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 64.40M | -1.89% | 334,094 | - |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 64.20M | -1.32% | 506,259 | - |
| 405 | IMA | ImageneBio, Inc. | 62.49M | -6.26% | 8,031 | 800.00K |
| 406 | HYFT | MindWalk Holdings Corp. | 60.26M | -4.44% | 179,093 | 11.43M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 59.20M | -1.77% | 111,550 | - |
| 408 | CRDF | Cardiff Oncology, Inc. | 58.48M | 0.52% | 581,849 | 525.00K |
| 409 | BOLD | Boundless Bio, Inc. | 56.16M | - | 105,465 | - |
| 410 | INO | Inovio Pharmaceuticals, Inc. | 55.70M | 3.20% | 12,490,765 | 65.34K |
| 411 | DWTX | Dogwood Therapeutics, Inc. | 55.15M | 3.80% | 50,163 | - |
| 412 | CNTX | Context Therapeutics Inc. | 55.07M | -1.30% | 964,913 | - |
| 413 | MREO | Mereo BioPharma Group plc | 54.70M | 8.79% | 2,708,143 | 500.00K |
| 414 | XLO | Xilio Therapeutics, Inc. | 54.50M | 0.33% | 11,431 | 53.48M |
| 415 | INKT | MiNK Therapeutics, Inc. | 52.31M | -0.85% | 3,759 | - |
| 416 | FLNA | Filana Therapeutics, Inc. | 48.79M | 5.21% | 335,096 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 48.56M | -1.68% | 253,902 | 9.14M |
| 418 | TIL | Instil Bio, Inc. | 48.29M | -0.28% | 10,380 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 47.62M | 1.19% | 396,650 | 190.00K |
| 420 | IMMP | Immutep Limited | 47.59M | 0.58% | 173,001 | 5.28M |
| 421 | BYSI | BeyondSpring Inc. | 47.29M | 1.77% | 8,666 | 1.88M |
| 422 | MCRB | Seres Therapeutics, Inc. | 46.77M | 1.05% | 51,072 | 1.15M |
| 423 | INMB | INmune Bio Inc. | 46.52M | -1.13% | 225,745 | 50.00K |
| 424 | IBO | Impact BioMedical Inc. | 46.36M | - | 10,915 | 39.00K |
| 425 | EDSA | Edesa Biotech, Inc. | 45.44M | -2.67% | 53,984 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 44.80M | -2.46% | 135,743 | 22.33M |
| 427 | VRXA | Veraxa Biotech AG | 44.38M | -10.20% | 310,816 | - |
| 428 | KPTI | Karyopharm Therapeutics Inc. | 43.51M | -72.61% | 22,363,540 | 151.12M |
| 429 | RNXT | RenovoRx, Inc. | 43.22M | 1.82% | 244,966 | 1.49M |
| 430 | HYPD | Hyperion DeFi, Inc. | 40.02M | -0.75% | 358,127 | 1.04M |
| 431 | EXOZ | eXoZymes, Inc. | 39.43M | 1.09% | 2,270 | -700.00 |
| 432 | RADX | Radiopharm Theranostics Limited | 38.61M | -1.56% | 93,672 | 10.86M |
| 433 | PDSB | PDS Biotechnology Corporation | 38.30M | -1.85% | 163,778 | - |
| 434 | DYAI | Dyadic International, Inc. | 38.26M | -1.87% | 122,807 | 3.81M |
| 435 | APLM | Apollomics, Inc. | 37.87M | -0.61% | 5,252 | 8.84M |
| 436 | VERU | Veru Inc. | 35.95M | 0.90% | 153,599 | 16.89M |
| 437 | GNTA | Genenta Science S.p.A. | 35.15M | -1.32% | 27,995 | - |
| 438 | CRVO | CervoMed Inc. | 34.90M | 2.38% | 238,417 | 2.09M |
| 439 | NTRB | Nutriband Inc. | 34.64M | -2.06% | 8,724 | 1.80M |
| 440 | NNVC | NanoViricides, Inc. | 34.63M | -1.94% | 126,170 | - |
| 441 | GRCE | Grace Therapeutics, Inc. | 33.85M | 0.48% | 177,498 | - |
| 442 | ENLV | Enlivex Ltd. | 33.59M | 7.18% | 341,449 | - |
| 443 | LTRN | Lantern Pharma Inc. | 33.56M | -0.75% | 47,878 | - |
| 444 | LITS | Lite Strategy, Inc. | 32.78M | -2.40% | 65,069 | - |
| 445 | BCTX | BriaCell Therapeutics Corp. | 31.66M | -5.23% | 61,539 | - |
| 446 | ESLA | Estrella Immunopharma, Inc. | 30.71M | -0.89% | 6,435 | - |
| 447 | SER | Serina Therapeutics, Inc. | 30.00M | -1.96% | 9,325 | 130.00K |
| 448 | TVGN | Tevogen Bio Holdings Inc. | 29.75M | 4.91% | 10,663 | - |
| 449 | KYNB | Kyntra Bio, Inc. | 27.24M | -0.88% | 4,645 | 7.44M |
| 450 | PSTV | Plus Therapeutics, Inc. | 26.64M | 6.03% | 96,526 | 5.18M |
| 451 | ACTU | Actuate Therapeutics, Inc. | 26.56M | -5.13% | 157,073 | - |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 26.26M | -0.01% | 34,397 | 90.00K |
| 453 | ALGS | Aligos Therapeutics, Inc. | 26.18M | -2.08% | 49,029 | 4.71M |
| 454 | ABVC | ABVC BioPharma, Inc. | 25.52M | -6.48% | 25,417 | 797.92K |
| 455 | IGC | IGC Pharma, Inc. | 24.92M | -0.20% | 165,465 | 1.11M |
| 456 | EVAX | Evaxion A/S | 23.52M | -0.35% | 15,465 | 7.53M |
| 457 | QNCX | Quince Therapeutics, Inc. | 22.87M | 1.56% | 35,220 | - |
| 458 | BRNS | Barinthus Biotherapeutics plc | 22.79M | 0.14% | 11,356 | 14.97M |
| 459 | LGVN | Longeveron Inc. | 22.17M | 3.88% | 650,162 | 1.22M |
| 460 | PLRZ | Polyrizon Ltd. | 21.06M | -3.18% | 97,225 | - |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 20.97M | -1.02% | 37,271 | -13.27K |
| 462 | CLRB | Cellectar Biosciences, Inc. | 20.54M | 1.58% | 129,322 | - |
| 463 | CVM | CEL-SCI Corporation | 20.27M | -4.92% | 163,603 | - |
| 464 | SKYE | Skye Bioscience, Inc. | 19.98M | -2.03% | 147,837 | - |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 19.70M | - | 185,418 | - |
| 466 | GRDX | GridAI Technologies Corp. | 19.29M | -4.92% | 62,778 | - |
| 467 | ALLR | Allarity Therapeutics, Inc. | 19.25M | -1.63% | 39,363 | 345.00K |
| 468 | MRKR | Marker Therapeutics, Inc. | 18.84M | 0.89% | 37,439 | 3.55M |
| 469 | NCEL | NewcelX Ltd. | 18.79M | 3.83% | 10,099 | - |
| 470 | CELU | Celularity Inc. | 18.39M | -6.57% | 80,001 | 26.55M |
| 471 | DARE | Daré Bioscience, Inc. | 18.27M | -1.61% | 69,562 | 1.16M |
| 472 | QNTM | Quantum BioPharma Ltd. | 18.27M | 1.76% | 49,972 | - |
| 473 | ATOS | Atossa Therapeutics, Inc. | 17.83M | -5.48% | 78,964 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 17.64M | 1.48% | 523,776 | - |
| 475 | LPCN | Lipocine Inc. | 17.48M | 0.47% | 29,434 | 2.00M |
| 476 | HOWL | Werewolf Therapeutics, Inc. | 17.16M | -29.44% | 2,955,885 | 1.14M |
| 477 | PLUR | Pluri Inc. | 16.72M | -0.64% | 35,900 | 1.08M |
| 478 | NRSN | NeuroSense Therapeutics Ltd. | 16.44M | -2.27% | 87,619 | - |
| 479 | CALC | CalciMedica, Inc. | 15.80M | 19.05% | 514,826 | - |
| 480 | OSRH | OSR Health, Inc. | 15.73M | 4.19% | 476,318 | 2.63M |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 15.65M | -9.81% | 249,382 | 5.61M |
| 482 | KTTA | Pasithea Therapeutics Corp. | 15.37M | 3.58% | 252,561 | - |
| 483 | NXTC | NextCure, Inc. | 14.97M | -17.59% | 385,645 | - |
| 484 | HIND | Vyome Holdings, Inc. | 14.84M | 5.22% | 21,994 | 152.72K |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 14.59M | -1.71% | 15,671 | 1.99M |
| 486 | PASG | Passage Bio, Inc. | 14.34M | -0.45% | 4,973 | - |
| 487 | KALA | KALA BIO, Inc. | 14.05M | 3.59% | 71,480 | - |
| 488 | MLEC | Moolec Science SA | 14.00M | -6.53% | 3,314 | 7.83M |
| 489 | AKTX | Akari Therapeutics, Plc | 13.76M | -1.75% | 14,598 | - |
| 490 | BIOT | Instinct Brothers Co., Ltd. | 13.60M | -5.41% | 855,793 | - |
| 491 | PTN | Palatin Technologies, Inc. | 13.08M | -1.41% | 5,785 | 12.88M |
| 492 | BLRX | BioLineRx Ltd. | 12.83M | 4.44% | 9,640 | 1.40M |
| 493 | TPST | Tempest Therapeutics, Inc. | 12.68M | -0.86% | 69,478 | - |
| 494 | ICU | SeaStar Medical Holding Corporation | 12.58M | -1.57% | 81,286 | 1.44M |
| 495 | PBM | Psyence Biomedical Ltd. | 12.09M | -5.65% | 70,402 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 11.91M | -0.49% | 89,541 | - |
| 497 | BIVI | BioVie Inc. | 11.46M | 6.29% | 203,811 | - |
| 498 | KPRX | Kiora Pharmaceuticals, Inc. | 11.35M | 0.20% | 4,501 | 20.00K |
| 499 | COCP | Cocrystal Pharma, Inc. | 11.31M | -5.50% | 33,039 | 225.00K |
| 500 | INTS | Intensity Therapeutics, Inc. | 11.22M | 2.47% | 78,095 | - |